VAXCYTE, INC. Operating Leases, Rent Expense, Net
VAXCYTE, INC. (PCVX) reported Operating Leases, Rent Expense, Net of $700.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2021-03-29
- VAXCYTE, INC. operating leases, rent expense, net for the quarter ending 2020-12-31 was $200.00K, a 0.00% change year-over-year.
- VAXCYTE, INC. operating leases, rent expense, net for the quarter ending 2020-09-30 was $200.00K, a 0.00% change year-over-year.
- VAXCYTE, INC. operating leases, rent expense, net for the quarter ending 2020-06-30 was $200.00K, a 100.00% increase year-over-year.
- VAXCYTE, INC. operating leases, rent expense, net for the quarter ending 2020-03-31 was $100.00K.
- VAXCYTE, INC. operating leases, rent expense, net for fiscal 2020 was $700.00K, a 16.67% increase from fiscal 2019.
- VAXCYTE, INC. operating leases, rent expense, net for fiscal 2019 was $600.00K, a 50.00% increase from fiscal 2018.
- VAXCYTE, INC. operating leases, rent expense, net for fiscal 2018 was $400.00K.
| Period end | Operating Leases, Rent Expense, Net 3 month | Operating Leases, Rent Expense, Net 6 month | Operating Leases, Rent Expense, Net 9 month | Operating Leases, Rent Expense, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $400.00K derived: sum of 2 quarters · filed 2021-03-29 | $600.00K derived: sum of 3 quarters · filed 2021-03-29 | $700.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $200.00K 10-Q · filed 2020-11-12 | $400.00K derived: sum of 2 quarters · filed 2020-11-12 | $500.00K 10-Q · filed 2020-11-12 | $700.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2020-06-30 | $200.00K 10-Q · filed 2020-08-12 | $300.00K 10-Q · filed 2020-08-12 | $500.00K derived: sum of 3 quarters · filed 2021-03-29 | $700.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2020-03-31 | $100.00K derived: 10-K 12 month − 3 quarters · filed 2021-03-29 | $300.00K derived: sum of 2 quarters · filed 2021-03-29 | $500.00K derived: sum of 3 quarters · filed 2021-03-29 | $600.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $400.00K derived: sum of 2 quarters · filed 2021-03-29 | $500.00K derived: sum of 3 quarters · filed 2021-03-29 | $600.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $200.00K 10-Q · filed 2020-11-12 | $300.00K derived: sum of 2 quarters · filed 2020-11-12 | $400.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $100.00K 10-Q · filed 2020-08-12 | $200.00K 10-Q · filed 2020-08-12 | ||
| 2018-12-31 | $400.00K 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |